1027856-54-7

Basic information

• Product Name: (6-bromohexyl)diphenylamine
• Synonyms: (6-bromohexyl)diphenylamine
• CAS NO: 1027856-54-7
• Molecular Weight: 332.283
• Mol File: 1027856-54-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (6-bromohexyl)diphenylamine(CAS DataBase Reference)
• NIST Chemistry Reference: (6-bromohexyl)diphenylamine(1027856-54-7)
• EPA Substance Registry System: (6-bromohexyl)diphenylamine(1027856-54-7)

Safety Data

• Hazardous Substances Data: 1027856-54-7(Hazardous Substances Data)

Usage

Description

(6-bromohexyl)diphenylamine, with the chemical formula C18H22BrN, is a derivative of diphenylamine. It is a pale yellow to brown solid that is soluble in organic solvents. (6-bromohexyl)diphenylamine is recognized for its antioxidant properties, which make it a valuable additive in the industry.

Uses

Used in Rubber Industry:
(6-bromohexyl)diphenylamine is used as an antioxidant for enhancing the stability and durability of rubber materials. It functions by scavenging free radicals, thus preventing the oxidation and degradation of rubber, leading to an extended lifespan and improved performance of the final product.
Used in Lubricant Applications:
In the lubricant industry, (6-bromohexyl)diphenylamine serves as an antioxidant to protect lubricants from oxidative degradation. Its addition ensures the maintenance of the lubricant's properties over time, reducing wear and tear on machinery and prolonging the service life of the lubricant.
Environmental Considerations:
(6-bromohexyl)diphenylamine is considered to be relatively low in toxicity and has a minimal environmental impact, making it a preferred choice for applications where ecological concerns are paramount.

Upstream product

• 629-03-8 1 ,6-dibromohexane 
• 122-39-4 diphenylamine 

Downstream Products

• 1376329-98-4 (6-phenothiazin-10-yl-hexyl)diphenylamine 
• 1376330-06-1 (2E)-3-{4-[(6-{3-[(1E)-2-cyano-2-(5-formylthiophen-2-yl)eth-1-en-1-yl]-10H-phenothiazin-10-yl}hexyl)(phenyl)amino]phenyl}-2-(5-formylthiophen-2-yl)prop-2-enenitrile 
• 1376329-90-6 (2E)-3-{9-[6-({4-[(1E)-2-carboxy-2-cyanoeth-1-en-1-yl]phenyl}(phenyl)amino)hexyl]-9H-carbazol-3-yl}-2-cyanoprop-2-enoic acid 
• 1376329-93-9 (E)-3-[4-({6-[3-((E)-2-carboxy-2-cyanovinyl)phenothiazin-10-yl]-hexyl}-phenylamino)phenyl]-2-cyanoacrylic acid 
• 1376329-94-0 (2E)-3-{5-[(1E)-2-{4-[(6-{3-[(1E)-2-{5-[(1E)-2-carboxy-2-cyanoeth-1-en-1-yl]thiophen-2-yl}-2-cyanoeth-1-en-1-yl]-10H-phenothiazin-10-yl}hexyl)(phenyl)amino]phenyl}-1-cyanoeth-1-en-1-yl]thiophen-2-yl}-2-cyanoprop-2-enoic acid 
• 1376330-04-9 (2E)-3-{4-[(6-{3-[(1E)-2-cyano-2-(thiophen-2-yl)eth-1-en-1-yl]-10H-phenothiazin-10-yl}hexyl)(phenyl)amino]phenyl}-2-(thiophen-2-yl)prop-2-enenitrile 
• 1376330-00-5 9-{6-[(4-formylphenyl)(phenyl)amino]hexyl}-9H-carbazole-3-carbaldehyde 
• 1376330-01-6 10-{6-[(4-formylphenyl)(phenyl)amino]hexyl}-10H-phenothiazine-3-carbaldehyde 
• 1334037-46-5 10-{6-[(4-formylphenyl)phenylamino]hexyl}-10H-phenoxazine-3-carbaldehyde 
• 1334037-49-8 (E)-3-{5-[(E)-2-(4-{[6-(3-{(E)-2-[5-((E)-2-carboxy-2-cyanovinyl)thiophen-2-yl]-2-cyanovinyl}phenoxazin-10-yl)hexyl]phenylamino}phenyl)-1-cyanovinyl]thiophen-2-yl}-2-cyanoacrylic acid 
• 1334037-48-7 (E)-3-{4-[(6-{3-[(E)-2-cyano-2-(5-formylthiophen-2-yl )vinyl]phenoxazin-10-yl}hexyl)phenylamino]phenyl}-2-(5-formylthiophen-2-yl)acrylonitrile 
• 1334037-47-6 (E)-3-[4-({6-[3-((E)-2-cyano-2-thiophen-2-yl-vinyl)phenoxazin-10-yl]hexyl}phenylamino)phenyl]-2-thiophen-2-ylacrylonitrile 
• 1334037-45-4 (6-phenoxazin-10-yl-hexyl)diphenylamine 
• 136058-93-0 (R)-1-(6-(diphenylamino)-1-hexyl)-3-piperidinecarboxylic acid ethyl ester 

Relevant articles and documents

Organic dye bearing asymmetric double donor-π-Acceptor chains for dye-sensitized solar cells

A novel efficient metal free sensitizer containing asymmetric double donor-π-acceptor chains (DC) was synthesized for dye-sensitized solar cells (DSSCs). Comparing to 3.80%, 4.40% and 4.64% for the DSSCs based on the dyes with single chain (SC1, SC2) and

Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates

By bioisosteric transformations and successive optimization of known GABA uptake inhibitors, several series of novel GABA uptake inhibitors have been prepared by different synthetic approaches. These compounds are derivatives of nipecotic acid and guvacine, substituted at the nitrogen of these amino acids by various lipophilic moieties such as diarylaminoalkoxyalkyl or diarylalkoxyalkyl. The in vitro values for inhibition of [3H]GABA uptake in rat synaptosomes was determined for each compound, and it was found that the most potent compound from this series, (R)-1-(2-(3,3-diphenyl-1-propyloxy)ethyl)-3-piperidinecarboxylic acid hydrochloride (29), is so far the most potent parent compound inhibiting GABA uptake into synaptosomes. Structure-activity results confirm our earlier observations, that an electronegative center in the chain connecting the amino acid and diaryl moiety is very critical in order to obtain high in vitro potency. Several of the novel compounds were also evaluated for their ability in vivo to inhibit clonic seizures induced by a 15 mg/kg (ip) dose of methyl 6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate (DMCM). Some of the compounds tested show a high in vivo potency comparable with that of the recently launched anticonvulsant product 6 ((R)-1-(4,4-bis(3-methyl-2- thienyl)-3-butenyl)-3-piperidinecarboxylic acid).